![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Signs Definitive Agreement to Raise $1.2155 Million in Registered Direct Offering
September 17, 2009 08:26 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 17, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Announces Receipt of NASDAQ Letter Citing Non-Compliance With Minimum Bid Price Rules
September 17, 2009 08:25 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 17, 2009 (GLOBE NEWSWIRE) -- On September 15, 2009, DARA BioSciences, Inc. (Nasdaq:DARA) received a notice from The NASDAQ Stock Market stating that the minimum bid price of the...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Will Present Phase 2a Study Results for KRN5500 At the "12th International Conference on the Mechanisms and Treatment of Neuropathic Pain" Meeting
September 15, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 15, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that results of its KRN5500 study have been selected for presentation at the 12th International...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Signs Definitive Agreement to Raise $2.5 Million in Registered Direct Offering
September 11, 2009 10:04 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 11, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Reports On SurgiVision's Co-Development Agreement With Siemens Healthcare
September 10, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 10, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that SurgiVision, Inc., a privately held company of which DARA owns approximately 7.3% of the...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences, Inc. and America Stem Cell, Inc. Collaborate On Stem Cell Research
August 04, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 4, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the Company is collaborating with America Stem Cell ("ASC") to expand on observations from...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Receives Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
July 24, 2009 16:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., July 24, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company"), a development-stage pharmaceutical company, announced today that the Company received an...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Releases Promising Preclinical Type 2 Diabetes Data for First-in-Class DB959
July 14, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., July 14, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) releases, today, a summary highlighting preclinical data for DB959, its lead compound for Type 2 Diabetes (T2D)...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences, Inc. Expands Its Patent Portfolio
June 25, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 25, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that as of June 11, 2009 it has gained the allowance and grant of an additional 10 patents to its...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Raises $1,397,000 Through the Sale of Common Stock and Warrants
June 16, 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 16, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), announced today that on June 15, 2009, it entered into and closed a securities purchase agreement (SPA) with...